Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.

<h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Myunhee Lee, Dae-Won Kim, Mahn-Won Park, Kyusup Lee, Sung-Ho Her, Kiyuk Chang, Wook Sung Chung, Myung Ho Jeong, Seung-Woon Rha, Hyo-Soo Kim, Hyeon Cheol Gwon, In Whan Seong, Kyung Kuk Hwang, Shung Chull Chae, Kwon-Bae Kim, Young Jo Kim, Kwang Soo Cha, Seok Kyu Oh, Jei Keon Chae, Ji-Hoon Jung, KAMIR-NIH registry investigators
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d80c512de032456a9b4e985d598d57ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d80c512de032456a9b4e985d598d57ad
record_format dspace
spelling oai:doaj.org-article:d80c512de032456a9b4e985d598d57ad2021-12-02T20:19:15ZMultivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.1932-620310.1371/journal.pone.0258525https://doaj.org/article/d80c512de032456a9b4e985d598d57ad2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258525https://doaj.org/toc/1932-6203<h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regarding optimal percutaneous coronary intervention (PCI) strategy for these patients. The aim of this study was to compare the long-term outcomes of IRA (infarct-related artery)-only and multivessel PCI in patients with NSTEMI and MVD complicated by severe LVSD.<h4>Methods</h4>Among 13,104 patients enrolled in the PCI registry from November 2011 to December 2015, patients with NSTEMI and MVD with severe LVSD who underwent successful PCI were screened. The primary outcome was 3-year major adverse cardiovascular events (MACEs), defined as all-cause death, any myocardial infarction, stroke, and any revascularization.<h4>Results</h4>Overall, 228 patients were treated with IRA-only PCI (n = 104) or MV-PCI (n = 124). The MACE risk was significantly lower in the MV-PCI group than in the IRA-only PCI group (35.5% vs. 54.8%; hazard ratio [HR] 0.561; 95% confidence interval [CI] 0.378-0.832; p = 0.04). This result was mainly driven by a significantly lower risk of all-cause death (23.4% vs. 41.4%; hazard ratio [HR] 0.503; 95% confidence interval [CI] 0.314-0.806; p = 0.004). The results were consistent after multivariate regression, propensity-score matching, and inverse probability weighting to adjust for baseline differences.<h4>Conclusions</h4>Among patients with NSTEMI and MVD complicated with severe LVSD, multivessel PCI was associated with a significantly lower MACE risk. The findings may provide valuable information to physicians who are involved in decision-making for these patients.Myunhee LeeDae-Won KimMahn-Won ParkKyusup LeeSung-Ho HerKiyuk ChangWook Sung ChungMyung Ho JeongSeung-Woon RhaHyo-Soo KimHyeon Cheol GwonIn Whan SeongKyung Kuk HwangShung Chull ChaeKwon-Bae KimYoung Jo KimKwang Soo ChaSeok Kyu OhJei Keon ChaeJi-Hoon JungKAMIR-NIH registry investigatorsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258525 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Myunhee Lee
Dae-Won Kim
Mahn-Won Park
Kyusup Lee
Sung-Ho Her
Kiyuk Chang
Wook Sung Chung
Myung Ho Jeong
Seung-Woon Rha
Hyo-Soo Kim
Hyeon Cheol Gwon
In Whan Seong
Kyung Kuk Hwang
Shung Chull Chae
Kwon-Bae Kim
Young Jo Kim
Kwang Soo Cha
Seok Kyu Oh
Jei Keon Chae
Ji-Hoon Jung
KAMIR-NIH registry investigators
Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
description <h4>Background</h4>A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regarding optimal percutaneous coronary intervention (PCI) strategy for these patients. The aim of this study was to compare the long-term outcomes of IRA (infarct-related artery)-only and multivessel PCI in patients with NSTEMI and MVD complicated by severe LVSD.<h4>Methods</h4>Among 13,104 patients enrolled in the PCI registry from November 2011 to December 2015, patients with NSTEMI and MVD with severe LVSD who underwent successful PCI were screened. The primary outcome was 3-year major adverse cardiovascular events (MACEs), defined as all-cause death, any myocardial infarction, stroke, and any revascularization.<h4>Results</h4>Overall, 228 patients were treated with IRA-only PCI (n = 104) or MV-PCI (n = 124). The MACE risk was significantly lower in the MV-PCI group than in the IRA-only PCI group (35.5% vs. 54.8%; hazard ratio [HR] 0.561; 95% confidence interval [CI] 0.378-0.832; p = 0.04). This result was mainly driven by a significantly lower risk of all-cause death (23.4% vs. 41.4%; hazard ratio [HR] 0.503; 95% confidence interval [CI] 0.314-0.806; p = 0.004). The results were consistent after multivariate regression, propensity-score matching, and inverse probability weighting to adjust for baseline differences.<h4>Conclusions</h4>Among patients with NSTEMI and MVD complicated with severe LVSD, multivessel PCI was associated with a significantly lower MACE risk. The findings may provide valuable information to physicians who are involved in decision-making for these patients.
format article
author Myunhee Lee
Dae-Won Kim
Mahn-Won Park
Kyusup Lee
Sung-Ho Her
Kiyuk Chang
Wook Sung Chung
Myung Ho Jeong
Seung-Woon Rha
Hyo-Soo Kim
Hyeon Cheol Gwon
In Whan Seong
Kyung Kuk Hwang
Shung Chull Chae
Kwon-Bae Kim
Young Jo Kim
Kwang Soo Cha
Seok Kyu Oh
Jei Keon Chae
Ji-Hoon Jung
KAMIR-NIH registry investigators
author_facet Myunhee Lee
Dae-Won Kim
Mahn-Won Park
Kyusup Lee
Sung-Ho Her
Kiyuk Chang
Wook Sung Chung
Myung Ho Jeong
Seung-Woon Rha
Hyo-Soo Kim
Hyeon Cheol Gwon
In Whan Seong
Kyung Kuk Hwang
Shung Chull Chae
Kwon-Bae Kim
Young Jo Kim
Kwang Soo Cha
Seok Kyu Oh
Jei Keon Chae
Ji-Hoon Jung
KAMIR-NIH registry investigators
author_sort Myunhee Lee
title Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
title_short Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
title_full Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
title_fullStr Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
title_full_unstemmed Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.
title_sort multivessel versus ira-only pci in patients with nstemi and severe left ventricular systolic dysfunction.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d80c512de032456a9b4e985d598d57ad
work_keys_str_mv AT myunheelee multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT daewonkim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT mahnwonpark multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kyusuplee multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT sunghoher multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kiyukchang multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT wooksungchung multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT myunghojeong multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT seungwoonrha multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT hyosookim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT hyeoncheolgwon multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT inwhanseong multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kyungkukhwang multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT shungchullchae multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kwonbaekim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT youngjokim multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kwangsoocha multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT seokkyuoh multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT jeikeonchae multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT jihoonjung multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
AT kamirnihregistryinvestigators multivesselversusiraonlypciinpatientswithnstemiandsevereleftventricularsystolicdysfunction
_version_ 1718374255119302656